Degarelix Drug Product
Patent No. EP4512389 (titled "Degarelix Drug Product") was filed by Ferring on May 31, 2013. The application was issued on Feb 4, 2026.
Patent Summary
UPC Cases New
Latest UPC cases involving this patent.
Patent Family
Statuses, jurisdictions and citation links are shared on request.
Patent Oppositions
Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.
Dossier Documents
The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.
Date
Description
EP4512389
- Application Number
- EP25151066A
- Filing Date
- May 31, 2013
- Status
- Granted And Under Opposition
- Jan 1, 2026
- Publication Date
- Feb 4, 2026
- External Links
- Slate, Register , Google Patents